There’s a new scandal rocking the healthcare industry. Officials have confirmed that counterfeit N95 face masks have started circulating within the U.S., and several healthcare facilities have handed them out.
Every N.J. COVID vaccine site handles appointments differently. Here’s how to register in every county. (2/12/21)
Updated Feb 12, 2021;
Posted Feb 12, 2021
A line forms at the new Gloucester County COVID-19 vaccination site in Sewell on Jan. 11, 2021.
Facebook Share
Eligible New Jersey residents are slowly but surely becoming inoculated for the coronavirus as the number of entities distributing the vaccine grow throughout the state.
Individuals qualified to receive the vaccine include those in priority groups, specifically healthcare professionals, first responders, people over the age of 65, and those with chronic health conditions.
New Jersey does not have a streamlined vaccine appointment system, meaning that a countless of number of counties, municipalities, healthcare systems and other entities can take appointments themselves.
The weekend is a weekend for lover's ... it's Valentine's Day this Sunday, February 14th and if you are thinking something sweet for your sweetheart how about something that's both tasty and heart healthy
As many as 1.9 million counterfeit 3M masks made their way to about 40 hospitals in Washington state, according to the state hospital association, spurring officials to alert staff members and pull them off the shelf. The elite Cleveland Clinic recently conceded that, since November, it had inadvertently distributed 3M counterfeits to hospital staffers. A Minnesota hospital made a similar admission.
Thursday, February 11, 2021
Marisa E. Poncia
Despite initial obstacles because of the COVID-19 pandemic, 2020 rounded out to be the busiest year for mergers and acquisitions (M&A) enforcement in the United States in nearly two decades. In the fourth quarter, US agencies challenged five transactions. November 2020 saw the most premerger filings in any month since 2001. Mergers and filings in the United States are predicted to remain at high levels into the new year in light of the current economic climate. The antitrust agencies have continued to maintain that their evaluation and investigation of anticompetitive harm will remain rigorous despite the uncertain times.